Logo image of OPTX

SYNTEC OPTICS HOLDINGS INC (OPTX) Stock Fundamental Analysis

NASDAQ:OPTX - Nasdaq - US87169M1053 - Common Stock - Currency: USD

1.37  -0.02 (-1.44%)

After market: 1.3999 +0.03 (+2.18%)

Fundamental Rating

2

Taking everything into account, OPTX scores 2 out of 10 in our fundamental rating. OPTX was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. OPTX has a bad profitability rating. Also its financial health evaluation is rather negative. OPTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

OPTX had positive earnings in the past year.
In the past year OPTX had a positive cash flow from operations.
OPTX Yearly Net Income VS EBIT VS OCF VS FCFOPTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 1M 2M 3M 4M

1.2 Ratios

OPTX's Return On Assets of 3.79% is fine compared to the rest of the industry. OPTX outperforms 68.00% of its industry peers.
Looking at the Return On Equity, with a value of 8.54%, OPTX is in the better half of the industry, outperforming 73.60% of the companies in the same industry.
The Return On Invested Capital of OPTX (1.38%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.79%
ROE 8.54%
ROIC 1.38%
ROA(3y)5.81%
ROA(5y)N/A
ROE(3y)14.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPTX Yearly ROA, ROE, ROICOPTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 20 30

1.3 Margins

OPTX has a Profit Margin of 2.05%. This is in the better half of the industry: OPTX outperforms 60.80% of its industry peers.
OPTX has a Operating Margin (0.79%) which is comparable to the rest of the industry.
OPTX's Gross Margin of 24.99% is in line compared to the rest of the industry. OPTX outperforms 41.60% of its industry peers.
Industry RankSector Rank
OM 0.79%
PM (TTM) 2.05%
GM 24.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OPTX Yearly Profit, Operating, Gross MarginsOPTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 10 15 20 25

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OPTX is destroying value.
The number of shares outstanding for OPTX has been reduced compared to 1 year ago.
OPTX has a better debt/assets ratio than last year.
OPTX Yearly Shares OutstandingOPTX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
OPTX Yearly Total Debt VS Total AssetsOPTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

OPTX has an Altman-Z score of 4.57. This indicates that OPTX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.57, OPTX is in the better half of the industry, outperforming 70.40% of the companies in the same industry.
OPTX has a Debt/Equity ratio of 0.88. This is a neutral value indicating OPTX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.88, OPTX is doing worse than 91.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z 4.57
ROIC/WACC0.16
WACC8.53%
OPTX Yearly LT Debt VS Equity VS FCFOPTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2M 4M 6M 8M 10M

2.3 Liquidity

OPTX has a Current Ratio of 1.34. This is a normal value and indicates that OPTX is financially healthy and should not expect problems in meeting its short term obligations.
OPTX has a worse Current ratio (1.34) than 81.60% of its industry peers.
OPTX has a Quick Ratio of 1.34. This is a bad value and indicates that OPTX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of OPTX (0.63) is worse than 92.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.63
OPTX Yearly Current Assets VS Current LiabilitesOPTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 218.00% over the past year.
OPTX shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
EPS 1Y (TTM)218%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)5.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPTX Yearly Revenue VS EstimatesOPTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 5M 10M 15M 20M 25M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.25, OPTX can be considered very expensive at the moment.
OPTX's Price/Earnings is on the same level as the industry average.
OPTX is valuated rather expensively when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.25
Fwd PE N/A
OPTX Price Earnings VS Forward Price EarningsOPTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OPTX indicates a somewhat cheap valuation: OPTX is cheaper than 64.80% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.37
OPTX Per share dataOPTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OPTX!.
Industry RankSector Rank
Dividend Yield N/A

SYNTEC OPTICS HOLDINGS INC

NASDAQ:OPTX (7/3/2025, 7:58:23 PM)

After market: 1.3999 +0.03 (+2.18%)

1.37

-0.02 (-1.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-22 2025-05-22
Earnings (Next)08-11 2025-08-11
Inst Owners0.69%
Inst Owner Change1.97%
Ins OwnersN/A
Ins Owner Change0%
Market Cap50.27M
AnalystsN/A
Price TargetN/A
Short Float %0.17%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 34.25
Fwd PE N/A
P/S 0.99
P/FCF N/A
P/OCF 28.63
P/B 4.15
P/tB 4.23
EV/EBITDA 17.37
EPS(TTM)0.04
EY2.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.05
OCFY3.49%
SpS1.38
BVpS0.33
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.79%
ROE 8.54%
ROCE 2.39%
ROIC 1.38%
ROICexc 1.41%
ROICexgc 1.43%
OM 0.79%
PM (TTM) 2.05%
GM 24.99%
FCFM N/A
ROA(3y)5.81%
ROA(5y)N/A
ROE(3y)14.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA 3.36
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 55.42%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 0.63
Altman-Z 4.57
F-Score6
WACC8.53%
ROIC/WACC0.16
Cap/Depr(3y)78.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)218%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y134.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y347.27%
OCF growth 3YN/A
OCF growth 5YN/A